Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Ruppert, Amy S
[Clear All Filters]
2024
Batchelor TT
,
Giri S
,
Ruppert AS
,
Geyer S
,
Smith SE
,
Mohile N
,
Swinnen LJ
,
Friedberg JW
,
Kahl BS
,
Bartlett NL
, et al.
Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101.
Blood Adv. 2024.
PubMed
Google Scholar
2023
Bhatnagar B
,
Zhao Q
,
Mims AS
,
Vasu S
,
Behbehani GK
,
Larkin K
,
Blachly JS
,
Badawi MA
,
Hill KL
,
Dzwigalski KR
, et al.
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.
Leuk Lymphoma. 2023:1-10.
PubMed
Google Scholar
2020
Kaplan LD
,
Maurer MJ
,
Stock W
,
Bartlett NL
,
Fulton N
,
Pettinger A
,
Byrd JC
,
Blum KA
,
Lacasce AS
,
Hsi ED
, et al.
Bortezomib Consolidation or Maintenance Following Immunochemotherapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: CALGB/Alliance 50403.
Am J Hematol. 2020.
PubMed
Google Scholar
2019
Issa H
,
Sharma N
,
Zhao Q
,
Ruppert AS
,
Elder P
,
Benson DM
,
Penza S
,
Vasu S
,
William B
,
Jaglowski S
, et al.
Comparison of Two Doses of Antithymocyte Globulin in Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (allo HSCT).
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
2016
Chen TL
,
Gupta N
,
Lehman A
,
Ruppert AS
,
Yu L
,
Oakes CC
,
Claus R
,
Plass C
,
Maddocks KJ
,
Andritsos L
, et al.
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.
Oncotarget. 2016.
PubMed
Google Scholar
2014
Salem G
,
Ruppert AS
,
Elder P
,
Hofmeister CC
,
Benson DM
,
Penza S
,
Andritsos L
,
Klisovic R
,
Vasu S
,
Blum W
, et al.
Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplant (allo HSCT).
Leuk Lymphoma. 2014:1-20.
PubMed
Google Scholar
Claus R
,
Lucas DM
,
Ruppert AS
,
Williams KE
,
Weng D
,
Patterson K
,
Zucknick M
,
Oakes CC
,
Rassenti LZ
,
Greaves AW
, et al.
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
Blood. 2014.
PubMed
Google Scholar